With every new technological innovation, the pharmaceutical industry moves closer to the broader introduction of automation in production lines. But what bumps in the road to progress need to be smoothed out when it comes to the standardisation of industry approaches?

In this Commentary article, we explore the applications of end-to-end automation in accelerating workflows through the use of robotics and informatics.

What is being done to overcome difficulties with supply chains, regulatory processes, and scalability?